Pharmasol has announced the availability of psiXchange version 2.4, which automates the safety document distribution process within clinical trials. PsiXchange is an automated system that establishes relationships between data from multiple sources. The new enhancements within this release include expanded site views, enabling support of clinical operations and site-based teams, and provides information in real-time to a variety of global recipients involved in the drug safety management chain.
Safety documents like suspected unexpected serious adverse reactions (SUSARs), line listings and development safety update reports (DSURs) can be sent to all recipients including sites, ECs (ethics committees), IRBs (institutional review boards), and others through Safety Central (the smart portal that is part of psiXchange). These safety documents are automatically distributed using the embedded country rules and recipients’ language preferences.
For more information, click here.